Belzutifan with lenvatinib for treating advanced renal cell carcinoma after a PD-1 or PD-L1 inhibitor [ID6476]

  • Awaiting development
  • GID-TA11584
  • Expected publication date: TBC

30655-Belzutifan-and-Lenvatinib-for-Renal-Cell-Carcinoma-V1.0-MAY2024-NON-CONF.pdf (nihr.ac.uk)